Balaxi Pharma Share Price

Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.As of 28 May 2026, Balaxi Pharma share price is ₹24.97. The stock opened at ₹25.49, compared to its previous close of ₹25.37. During today's trading session, Balaxi Pharma share price moved in the range of ₹24.11 to ₹25.90, with an average price of ₹25.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.11 and a high of ₹25.90. On the performance front, Balaxi Pharma share price has declined by 33.78% over the last six months and is down 51.96% on a year-on-year basis.

The market capitalization of Balaxi Pharma is ₹138 Crs, with a P/E ratio of 14.6 and a dividend yield of 0.00%.